28 Aug, EOD - Indian

SENSEX 81785.56 (0.09)

Nifty 50 25052.35 (0.14)

Nifty Bank 51143.85 (-0.26)

Nifty IT 42394.4 (1.64)

Nifty Midcap 100 59146.4 (-0.12)

Nifty Next 50 75082.55 (0.31)

Nifty Pharma 22989.1 (1.14)

Nifty Smallcap 100 19319.75 (-0.07)

28 Aug, EOD - Global

NIKKEI 225 38371.76 (0.22)

HANG SENG 17692.45 (-1.02)

S&P 5574.36 (-1.00)

LOGIN HERE

You are Here : Home > Markets > CompanyInformation > Company Background
BSE Code : | NSE Symbol : | ISIN : | Industry : |


Chairman's Speech

Dear Shareholders,

The Covid pandemic and geopolitical developments including the ongoing conflict in East Europe has elevated global economic uncertainty. Inflation driven by supply chain disruptions has impacted the economies across the world and the steps undertaken by the central banks for macroeconomic stability through tight monetary and fiscal policies has further dented consumer confidence across the world According to the report, the advanced economies are expected to be the most affected by the slowdown, while emerging markets and developing economies may experience a less pronounced impact.

TRUPCR? assays from our subsidiary company M/s 3B BlackBio Biotech India Limited have been well-accepted in over 35 countries across UK and Europe, Middle East, APAC, LATAM and United States of America. We have added few more countries across South-East Asia and Middle-East through our channel partners. We are working to add more channel partners across various countries to increase our global reach. Post Covid the number of Molecular diagnostic labs and the manufacturers have increased globally, still 3B BlackBio is well positioned to face the competition with its excellent product range, customer support and highly appreciated quality product.

We are also in the process of getting our products registered in the countries where there is a good demand as per the respective medical devices regulations which will allow us easy access and preference in those markets.

The Board of Directors has recommended a dividend of Rs. 2.50 per equity share of Rs. 10.00/- face value for the Shareholders' approval at the forthcoming Annual General Meeting.

As I reflect back on the year, I would like to convey special thanks to our supply and trade partners whose efforts made sure that our products were available at the right time and place.

With a defined strategy and a talented and engaged team to support its execution, we are confident in continuing this growth trajectory to meet our future growth targets, and to deliver long-term shareholder value.

Finally, I would like to thank all our employees, customers, stakeholders and associates and wish them every success in their lives.

JAI HIND

Shri Dhirendra Dubey Chairman & Managing Director